Grant: Engage Grants Program
University of British Columbia
$24,000.00
Improvement of new technology for assessment of adequate cerebral blood perfusion
EF 2017-18
Résumé
Cerebral autoregulation is a protective mechanism that maintains optimal brain blood flow and oxygen deliveryindependent of changes in blood pressure. However, this protective mechanism has limits; blood pressures thatare too high or too low may exceed the ability of the brain's autoregulation mechanism(s) leading to anexcessive level of under- or over- perfusion. For example, in surgical patients, blood pressure often exceeds theupper and/or lower limits of cerebral autoregulation, yet clinicians may not recognize that the patient's cerebralperfusion is compromised and thus do not intervene. This issue stems from an absence of evidence based,standardized and effective technology that can be used to evaluate cerebral autoregulation, especially inreal-time. Therefore, improved cerebral autoregulation monitoring technology capable of detecting andinforming clinicians about the patient's cerebral autoregulation and brain blood flow is necessary. The first stepto address this issue is the development of a standard for the improvement of cerebral autoregulationmonitoring technology: the company (Medtronic) and University (Prof Ainslie) will be required to define andsubstantiate cerebral autoregulation monitoring approaches as part of a technology development process.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
522435-2017
Name nom
Ainslie, Philip
Department département
Okanagan - Health and Social Development, Faculty of
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
24000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
9000
Research subject group en
Medical sciences
Research subject group fr
Sciences médicales
Research subject en
Medical sciences
Research subject fr
Sciences médicales
Partie
1
Nb partie
1
Application title
Improvement of new technology for assessment of adequate cerebral blood perfusion
Keyword
NSERC
Application summary
Cerebral autoregulation is a protective mechanism that maintains optimal brain blood flow and oxygen deliveryindependent of changes in blood pressure. However, this protective mechanism has limits; blood pressures thatare too high or too low may exceed the ability of the brain's autoregulation mechanism(s) leading to anexcessive level of under- or over- perfusion. For example, in surgical patients, blood pressure often exceeds theupper and/or lower limits of cerebral autoregulation, yet clinicians may not recognize that the patient's cerebralperfusion is compromised and thus do not intervene. This issue stems from an absence of evidence based,standardized and effective technology that can be used to evaluate cerebral autoregulation, especially inreal-time. Therefore, improved cerebral autoregulation monitoring technology capable of detecting andinforming clinicians about the patient's cerebral autoregulation and brain blood flow is necessary. The first stepto address this issue is the development of a standard for the improvement of cerebral autoregulationmonitoring technology: the company (Medtronic) and University (Prof Ainslie) will be required to define andsubstantiate cerebral autoregulation monitoring approaches as part of a technology development process.